Parasomnia

01Pathophysiology

Parasomnias are undesirable behavioral or experiential events that occur during entry into sleep, within sleep, or during arousal from sleep. The PPDGJ-III recognizes three primary non-organic parasomnias: Sleepwalking, Night Terrors, and Nightmares. Understanding them requires understanding the architecture of normal sleep.

Normal sleep cycles through NREM stages (N1, N2, N3) and REM sleep in approximately 90-minute cycles. The first third of the night is dominated by deep NREM slow-wave sleep (N3), while the second half of the night contains proportionally more REM sleep. This distribution is the single most important concept for localizing parasomnias within the sleep cycle.

Sleepwalking and Night Terrors are both disorders of arousal from NREM slow-wave sleep. They result from an incomplete transition out of deep N3 sleep, where the brain becomes partially activated (enough to produce complex motor behavior or intense fear) but the cortex remains insufficiently aroused to generate conscious awareness or memory encoding. This explains why patients have no recall of the event and why these episodes cluster in the first third of the night, when N3 sleep is most abundant. The PPDGJ-III explicitly notes that Sleepwalking and Night Terrors are closely related and share clinical and pathophysiological characteristics.

In Sleepwalking, the partial arousal activates locomotor circuits while the prefrontal cortex (responsible for judgment, planning, and memory) remains dormant. This produces the characteristic blank, staring face and purposeless ambulation. The patient's eyes are open, but there is no conscious processing. Attempts to communicate or redirect the person are largely unsuccessful, and forceful awakening is difficult.

In Night Terrors, the partial arousal triggers a sudden, intense activation of the autonomic nervous system and the amygdala-driven fear response while higher cortical processing remains suppressed. The result is an abrupt episode of screaming, panic, tachycardia, tachypnea, pupil dilation, and sweating. The individual is essentially experiencing raw, subcortical terror without the cortical ability to process, contextualize, or remember it. Each episode typically lasts 1 to 10 minutes.

Nightmares, by contrast, are a REM sleep phenomenon. During REM sleep, the cortex is highly active (producing vivid, story-like dream content), while voluntary motor activity is inhibited by brainstem-mediated atonia. When the dream content becomes threatening, the emotional load eventually causes a cortical awakening. Because the cortex was fully active during the dream, the patient wakes up fully alert, oriented, and able to recall the dream in vivid detail. The dream content typically involves threats to survival, safety, or self-worth. Nightmares characteristically occur in the second half of the night, reflecting the increased proportion of REM sleep during that period.

The critical teaching point here: the presence or absence of recall and the timing within the night are direct consequences of which sleep stage the event arises from. NREM events produce amnesia and occur early; REM events produce vivid recall and occur late.

02Classification and Clinical Manifestation

The PPDGJ-III diagnostic criteria emphasize that for all three conditions, there must be no evidence of an underlying organic mental disorder. This exclusion criterion ensures that parasomnias caused by neurological disease (e.g., seizure disorders, neurodegenerative conditions) are not misclassified.

03Diagnostic Workup

All three parasomnias are fundamentally clinical diagnoses. The workup begins with a thorough sleep history, ideally including collateral information from a bed partner or parent who has witnessed the events. The clinician should ask about the timing of episodes within the night (early vs. late), the patient's behavior during the event, the degree of responsiveness, and the presence or absence of recall afterward.

For Sleepwalking and Night Terrors, the history alone is usually sufficient to establish the diagnosis. However, the PPDGJ-III explicitly requires the clinician to exclude organic mental disorders, and for Sleepwalking, to distinguish it from Psychomotor Epilepsy (nocturnal frontal lobe epilepsy) and Dissociative Fugue. If the episodes are atypical in presentation (e.g., stereotyped movements suggesting seizure, onset in adulthood, episodes multiple times per night, or occurrence outside the first third of the night), a video-polysomnography with extended EEG montage is indicated to rule out epileptiform activity.

Key discriminating features from epilepsy include: epileptic events tend to be stereotyped and brief (under 2 minutes), may occur multiple times per night, and can arise from any sleep stage. Sleepwalking episodes are more prolonged, variable in behavior, and arise from N3. Dissociative Fugue, unlike Sleepwalking, occurs during wakefulness and involves purposeful travel with identity confusion.

For Nightmares, the diagnosis rests almost entirely on the patient's own report. The hallmark is a vivid, well-formed, frightening dream that the patient can recount in detail, followed by immediate full alertness. Polysomnography is rarely necessary but, if performed, will show awakening from REM sleep without the N3 arousals seen in Night Terrors. If Nightmares are frequent and severe, the clinician should screen for PTSD and other anxiety disorders, as Nightmares are a core feature of trauma-related conditions.

04Management and Treatment

Non-pharmacological management is the cornerstone of treatment for all three parasomnias. For NREM parasomnias (Sleepwalking and Night Terrors), the most important intervention is ensuring a safe sleeping environment. This includes locking doors and windows, placing the mattress on the floor if falls are a concern, removing obstacles and sharp objects from the bedroom, and installing alarms or bells on the bedroom door.

Sleep hygiene is critical for all three conditions. Sleep deprivation and irregular sleep schedules lower the arousal threshold and increase the proportion of N3 rebound sleep, thereby increasing the frequency of NREM parasomnia events. The patient should maintain a consistent bedtime and wake time, avoid stimulants (caffeine, screens) before bed, and ensure adequate total sleep duration.

Scheduled awakenings are a behavioral technique used for Sleepwalking and Night Terrors in which the parent gently rouses the child approximately 15 to 30 minutes before the usual time of the episode, then allows the child to return to sleep. This disrupts the N3 sleep cycle and prevents the abnormal partial arousal from occurring. This technique has been shown to significantly reduce episode frequency when used consistently over several weeks.

Pharmacological therapy is reserved for cases that are frequent, dangerous, or significantly distressing. Clonazepam (a long-acting benzodiazepine) at a dose of 0.25 to 0.5 mg taken at bedtime is the standard pharmacological option for both Sleepwalking and Night Terrors. It works by suppressing N3 slow-wave sleep, thereby reducing the substrate from which these episodes arise. Treatment should be prescribed as a short course (typically 2 to 4 weeks) and then tapered, as most pediatric cases resolve with maturation of sleep architecture.

For Nightmares, the treatment approach is fundamentally different because the underlying driver is usually psychological rather than a disorder of sleep-stage transition. Image Rehearsal Therapy (IRT) is the best-studied and most effective intervention. In IRT, the patient writes down the content of a recurrent nightmare, then deliberately modifies the storyline to a non-threatening version and mentally rehearses the new version during waking hours. This cognitive restructuring reduces nightmare frequency and intensity. For trauma-associated Nightmares (particularly in PTSD), prazosin, an alpha-1 adrenergic antagonist, is used at a starting dose of 1 mg at bedtime, titrated up as needed (typical effective dose 2 to 6 mg, maximum 15 mg). It reduces trauma-related nightmares by attenuating the noradrenergic hyperactivation during REM sleep. The first-dose effect of orthostatic hypotension must be monitored.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students lose points on parasomnia questions is by confusing Night Terrors with Nightmares. Both appear as "a frightened child waking up at night," and if you do not know where to look in the vignette, they are easy to conflate. The exam tests whether you can identify two key discriminators: timing (first third vs. second half of the night) and recall (absent vs. vivid). If the vignette says the child "screams, appears terrified, has a racing heart, and cannot be consoled, with no memory of the event the next morning," that is Night Terrors. If the vignette says the child "wakes up crying, describes a scary dream in detail, and is alert and oriented," that is Nightmares.

A second common trap involves Sleepwalking vs. Nocturnal Epilepsy. A vignette describing repeated episodes of complex motor behavior during sleep that are identical each time (stereotyped) should raise suspicion for epilepsy, not sleepwalking. The test-writer is checking whether you know to order an EEG or video-polysomnography in that scenario. The PPDGJ-III itself flags this distinction explicitly.

A third testing angle is the management question. Students often reach for pharmacotherapy, but the correct first step for Sleepwalking and Night Terrors is always parental reassurance and environmental safety, not medication. Pharmacotherapy (clonazepam) is reserved for severe, frequent, or dangerous episodes. For Nightmares, the tested intervention is Image Rehearsal Therapy for the general population and prazosin for trauma-related nightmares.

Finally, remember that the PPDGJ-III mandates exclusion of organic mental disorders for all three diagnoses. If a vignette includes a head injury, a known neurological condition, or substance use, the diagnosis shifts away from a primary parasomnia and toward a secondary cause. The core competency being tested is your ability to distinguish between closely related conditions using the timing, recall, autonomic features, and responsiveness described in the clinical scenario.